| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01747863 |
| P698 | PubMed publication ID | 4159524 |
| P2093 | author name string | E F Pfeiffer | |
| F Melani | |||
| H Ditschuneit | |||
| H Friedrich | |||
| K M Bartelt | |||
| P2860 | cites work | Immunoassay of endogenous plasma insulin in man | Q22306302 |
| THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY | Q39512876 | ||
| Evidence for the presence of insulin in blood serum; a method for an approximate determination of the insulin content of blood | Q40980961 | ||
| An immunochemical assay of total extractable insulin in man. | Q41012629 | ||
| Immunoassay of insulin with insulin-antibody precipitate | Q42961363 | ||
| Assay of Plasma Insulin in Human Subjects by Immunological Methods | Q59055483 | ||
| Estimation of plasma-insulin by the rat diaphragm method | Q73364506 | ||
| [A micro-method of immuno-electrophoresis] | Q73825157 | ||
| An assay for insulin-like activity using rat adipose tissue | Q78284826 | ||
| Preparation and purification of high specific activity insulin-131-iodine | Q79340767 | ||
| A simplified method for immuno-assay of human serum insulin | Q79446943 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 1000-1007 | |
| P577 | publication date | 1965-09-01 | |
| P1433 | published in | Klinische Wochenschrift | Q27711855 |
| P1476 | title | [On radio-immunologic determination of insulin in blood]. | |
| P478 | volume | 43 |
| Q66904264 | 5′-Guanylylimidodiphosphate: A modulator of glucagon-induced insulin release from isolated rat pancreatic islets |
| Q39167278 | A versatile microperifusion system |
| Q71745384 | Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient? |
| Q69625440 | Biochemical and haemodynamic effects of zinc-protamin-glucagon in man (author's transl) |
| Q68663389 | Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance |
| Q70169683 | Blood levels of branched-chain alpha-keto acids in uremia: effect of an oral glucose tolerance test |
| Q70259689 | Blood sugar, serum insulin and serum free fatty acid responses to graded glucose pulses in hypothyroid dogs |
| Q45243395 | Chronic treatment with thyroid-stimulating hormone. Its effects on blood sugar, serum insulin and free fatty acid levels in normal dogs tested for oral glucose tolerance |
| Q44534066 | Clinical pharmacology of two new oral antidiabetics of the sulfonamide type (author's transl) |
| Q68225063 | Comparison of human and porcine insulin therapies in children with newly diagnosed diabetes mellitus |
| Q40165583 | Comparison of α-ketoisocaproic acid and glucose in rats: Effects on insulin and somatostatin release and on islet camp content |
| Q71571115 | Contribution to the Pathogenesis of Tumour Hypoglycaemia |
| Q54030023 | Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test |
| Q69351398 | Cytochalasin B: Inhibition of glucose-induced insulin release from isolated rat pancreatic islets |
| Q67488496 | Cytochalasin B: evidence for a membrane-directed action in B-cells from rat pancreatic islets |
| Q54077657 | Dextran-coated charcoal immunoassay of insulin |
| Q51643357 | Different Response of Gastric Inhibitory Polypeptide to Glucose and Fat from Duodenum and Jejunum |
| Q68348428 | Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus |
| Q45054578 | Dynamics of insulin secretion in hypothyroidism prior and during substitution therapy |
| Q68177828 | Early and late effects of thyroid-stimulating hormone treatment. Studies on pancreas cytology, blood sugar, serum insulin and free fatty acids |
| Q67349337 | Effect of Lipids on Insulin, Growth Hormone and Exocrine Pancreatic Secretion in Man |
| Q69388419 | Effect of chronic cortisol treatment on the insulin response to hyperglycemia in thyroidectomized dogs |
| Q70142267 | Effects of a transplantable insulinoma upon regulatory peptide concentrations in the gastrointestinal tract of the rat |
| Q46291185 | Effects of chronic TSH treatment on blood sugar, serum IRI and FFA levels of thyroidectomized dogs. Glucose and insulin tolerance tests |
| Q46938397 | Effects of four orally administered analogues of prostaglandin E1 and E2 on glucose tolerance and on the secretion of pancreatic and gastrointestinal hormones in man. |
| Q70406330 | Effects of short-term thyroxine treatment on pancreatic cytology and responses of blood sugar, serum insulin and serum free fatty acids to epinephrine infusion |
| Q67065276 | Elimination of Hormones Through Hemofiltration |
| Q67354392 | Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation of food restriction |
| Q67275679 | Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels |
| Q41912305 | Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia |
| Q67787089 | Gastric inhibitory polypeptide (GIP), gastrin and insulin: response to test meal in coeliac disease and after duodeno-pancreatectomy |
| Q66902005 | Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro |
| Q69917816 | Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets |
| Q40381502 | Hepatotrophic Effects of Pancreatic and Gastrointestinal Hormones in the Ratin vivoandin vitro |
| Q46805028 | Human C-peptide. Part I: Radioimmunoassay |
| Q69645857 | Hyperglucagonemia of the isolated perfused pancreas of diabetic mice (db/db) |
| Q48668177 | Hypophysis and function of pancreatic islets. I. The influence of hypophysectomy on insulin secretion and biosynthesis of proinsulin and insulin in isolated pancreatic islets of rats |
| Q71980171 | Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon |
| Q39676765 | Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance |
| Q53679036 | In vitro studies of the rate of proinsulin and insulin turnover in seven human insulinomas. |
| Q42445991 | Increased somatostatin secretion from pancreatic islets of streptozotocin-diabetic rats in response to glucose |
| Q53928073 | Influence of atropine on the insulin secretion in man induced by intestinal hormones |
| Q69894222 | Influence of galactose on insulin secretion in humans |
| Q70284311 | Influence of insulin on blood levels of branched chain keto and amino acids in man |
| Q44090836 | Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat |
| Q43601489 | Insulin and glucose levels in umbilical cord blood after infusions of glucose and glucose with insulin to women in labour |
| Q40772586 | Insulin release from isolated rat pancreatic islets induced by α-ketoisocaproic acid, L-leucine, D-glucose or D-glyceraldehyde: Effect of gastric inhibitory polypeptide or glucagon |
| Q67833703 | Insulin secretion and biosynthesis in sucrose fed rats |
| Q39606500 | Insulin secretion in growth hormone-deficient children and the effect of the sulfonylurea drug glibenclamide on linear growth |
| Q67515557 | Insulin secretion in the perinatal period of the rat in vivo and in vitro effects of glucose and gibenclamide (HB 419) |
| Q44028814 | Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide |
| Q44495652 | Insulin, glucose tolerance and free fatty acids during and after acute hepatitis |
| Q69855527 | Intestinal hormones and insulin secretion |
| Q44197412 | Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. I. Body weight, carbohydrate metabolism and immunoreactive insulin |
| Q68153028 | Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man |
| Q44608862 | Leucine sensitive hypoglycemia. Follow-up studies under treatment with diazoxide (author's transl) |
| Q34472448 | Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon |
| Q44231518 | Morphometric and ultrastructural studies in an infant with leucine-sensitive hypoglycemia, hyperinsulinism and islet hyperplasia |
| Q72152606 | Necessity of glucose for long term blockade of the lipolysis with 3,5-dimethylisoxazole and 5-methylpyrazole-3-carboxylic acid |
| Q40746622 | Onset and reversibility of changes in secretory function and composition of isolated rat pancreatic islets following long-term administration of high or low tolbutamide doses |
| Q52717839 | Pentobarbital anaesthesia. Effects on blood sugar, serum immunoreactive insulin and free fatty acid responses to glucose |
| Q40065663 | Permissive effect of glucose on the glucagon-induced accumulation of cAMP in isolated rat pancreatic islets |
| Q34226184 | Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects |
| Q67252362 | Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose |
| Q71709421 | Plasma corticosteroids, free fatty acids, insulin and glucose in maternal blood during delivery |
| Q44547663 | Plasma profiles of insulin following intravenous administration in patients suffereing from kidney insufficiency |
| Q70275008 | Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption |
| Q69381365 | Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides |
| Q68865252 | Reduced incretin effect in type 2 (non-insulin-dependent) diabetes |
| Q71298882 | Relationship between fat and ketone body metabolism in obese and nonobese diabetics and nondiabetics during norepinephrine infusion |
| Q68211510 | Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency |
| Q72148637 | Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution |
| Q51665808 | Serum Gastric Inhibitory Polypeptide (GIP) in Duodenal Ulcer Disease: Relationship to Glucose Tolerance, Insulin, and Gastrin Release |
| Q70638730 | The behaviour of insulinaemia in patients with liver cirrhosis after intravenous administration of glucose, tolbutamide and glucagon |
| Q71689743 | The behaviour of the serum insulin level in non obese adult diabetics after intravenous glucose, tolbutamide and glucagon |
| Q69380502 | The effect of biguanides on secretion and biosynthesis of insulin in isolated pancreatic islets of rats |
| Q70376325 | The effect of dimethylbiguanide on glucose tolerance, serum insulin and growth hormone in obese patients |
| Q66956884 | The effect of phenformin on amino acid-induced insulin secretion in diabetics |
| Q69365760 | The effect of serotonin on in vitro insulin secretion and biosynthesis in mice |
| Q69378890 | The effect of tolbutamide and glibenclamide on the incorporation of [3 H]leucine and on the conversion of proinsulin to insulin in isolated pancreatic islets |
| Q33472612 | The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man |
| Q41041083 | The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in man |
| Q93761009 | The non specific effect of a serum factor on the radioimmunological insulin determination method of Hales and Randle |
| Q51689195 | The normal insulin response to glucose. The relationship between blood sugar and plasma insulin. |
| Q71439767 | The pancreatic beta-cell response to intravenous administration of glucose in elderly subjects |
| Q44109272 | The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. I. The effect of pancreozymin, secretin, gastrin-pentapeptide and of glucagon upon insulin secretion of isolated islets of rat pancreas |
| Q47752463 | The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. II. Insulin responses to secretin and pancreozymin in experimentally-induced pancreatic exocrine insufficiency |
| Q72151331 | The validity of C-peptide measurement in the diagnosis of factitious hypoglycemia |
| Q68835561 | Thyroidectomy and combined thyroxine-cortisol therapy. Their effects on blood sugar, serum immunoreactive insulin and free fatty acids during an oral glucose tolerance test |
| Q66904739 | Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets |
| Q72445062 | [Differential effect of long-term beta1-selective and nonselective beta-receptor blockade on carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)] |
| Q51687374 | [Effect of treatment with prednisolone on the secretion of insulin in rats]. |
| Q69626880 | [Glucose and insulin metabolism in patients undergoing regular dialysis treatment (author's transl)] |
| Q70377666 | [Influence of an isocaloric starch of sucrose-rich diet on insulin secretion and glucose assimilation] |
| Q71298873 | [Modification of the Hales-Randle procedure for the radioimmunoassay of insulin] |
Search more.